BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11686323)

  • 1. A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis.
    Jirousková M; Smyth SS; Kudryk B; Coller BS
    Thromb Haemost; 2001 Oct; 86(4):1047-56. PubMed ID: 11686323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody to the fibrinogen gamma-chain alters fibrin clot structure and its properties by producing short, thin fibers arranged in bundles.
    Scheiner T; Jirousková M; Nagaswami C; Coller BS; Weisel JW
    J Thromb Haemost; 2003 Dec; 1(12):2594-602. PubMed ID: 14675095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
    Huang TC; Jordan RE; Hantgan RR; Alevriadou BR
    Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
    Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic roles of the fibrinogen gamma chain.
    Farrell DH
    Curr Opin Hematol; 2004 May; 11(3):151-5. PubMed ID: 15257013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV; Jerome WG; Hantgan RR
    Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreading.
    Hamaguchi M; Bunce LA; Sporn LA; Francis CW
    Blood; 1994 Aug; 84(4):1143-50. PubMed ID: 8049430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function.
    Duval C; Allan P; Connell SD; Ridger VC; Philippou H; Ariëns RA
    Thromb Haemost; 2014 May; 111(5):842-50. PubMed ID: 24430058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor XIIIa is inactivated by plasmin.
    Hur WS; Mazinani N; Lu XJ; Britton HM; Byrnes JR; Wolberg AS; Kastrup CJ
    Blood; 2015 Nov; 126(20):2329-37. PubMed ID: 26359437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.
    Collet JP; Montalescot G; Lesty C; Soria J; Mishal Z; Thomas D; Soria C
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):142-8. PubMed ID: 11145946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain.
    Cho J; Degen JL; Coller BS; Mosher DF
    J Biol Chem; 2005 Oct; 280(42):35490-8. PubMed ID: 16051597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
    Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
    Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen gamma chain functions.
    Mosesson MW
    J Thromb Haemost; 2003 Feb; 1(2):231-8. PubMed ID: 12871494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.
    Rooney MM; Farrell DH; van Hemel BM; de Groot PG; Lord ST
    Blood; 1998 Oct; 92(7):2374-81. PubMed ID: 9746777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.